Results 291 to 300 of about 511,445 (325)

<i>Cynanchum wilfordii</i> modulates inflammatory responses in LPS-stimulated RAW264.7 cells via the NF-κB and MAPK pathways. [PDF]

J Enzyme Inhib Med Chem
Ji YJ, Kang MH, Han SH, Lee YS, Kim MJ, Kim JH, Jang GY.   +6 more
europepmc   +1 more source

Phytochemicals From <i>Houttuynia cordata</i> Thunb as Potential Inhibitors of BRAF, MEK, and ERK: Insights From Molecular Docking. [PDF]

J Skin Cancer
Yanarojana M, Tancharoen S, Nararatwanchai T, Yanarojana S.   +3 more
europepmc   +1 more source

Mechanism study of circCCDC134 regulating the biological behaviors of PDGF-BB-induced oral mucosal fibroblast. [PDF]

Sci Rep
Zhou Y, Jian N, Wang Q, Jiang C, Guo H, Wang J.   +5 more
europepmc   +1 more source

Pharmacologic Modulation of the PAR-2-ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells. [PDF]

Int J Mol Sci
Amiri L, Patnaik R, Varghese RL, Huda B, Banerjee Y.   +4 more
europepmc   +1 more source

Membrane potential modulates ERK activity and cell proliferation in human cells. [PDF]

Elife
Sasaki M, Nakahara M, Hashiguchi T, Ono F.   +3 more
europepmc   +1 more source

Transcriptional feedback of Erk signaling waves in zebrafish scale regeneration

Coudeville C, Guyomar T, Allamand J, Voigt F, De Simone A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HLA-DR meets ERK

Blood, 2010
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire   +2 more sources